United States Huntington's Disease Therapeutics Market Report 2016

October 2016 | 119 pages | ID: U77B7F92584EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Huntington's Disease Therapeutics

Revenue, means the sales value of Huntington's Disease Therapeutics

This report studies sales (consumption) of Huntington's Disease Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Auspex Pharmaceuticals
• Alnylam Pharmaceuticals
• Intellect Neurosciences Incorporation
• Lundbeck A/S
• Prana Biotechnology Limited
• Raptor Pharmaceuticals
• Sangamo Biosciences
• Teva Pharmaceutical Industries
• Trophos SA
• Valeant Pharmaceuticals International
• Vertex Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Huntington's Disease Therapeutics in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Huntington's Disease Therapeutics Market Report 2016

1 HUNTINGTON'S DISEASE THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Huntington's Disease Therapeutics
1.2 Classification of Huntington's Disease Therapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Huntington's Disease Therapeutics
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Huntington's Disease Therapeutics (2011-2021)
  1.4.1 United States Huntington's Disease Therapeutics Sales and Growth Rate (2011-2021)
  1.4.2 United States Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUNTINGTON'S DISEASE THERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 United States Huntington's Disease Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Huntington's Disease Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Huntington's Disease Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Huntington's Disease Therapeutics Market Competitive Situation and Trends
  2.4.1 Huntington's Disease Therapeutics Market Concentration Rate
  2.4.2 Huntington's Disease Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUNTINGTON'S DISEASE THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Huntington's Disease Therapeutics Sales and Market Share by Type (2011-2016)
3.2 United States Huntington's Disease Therapeutics Revenue and Market Share by Type (2011-2016)
3.3 United States Huntington's Disease Therapeutics Price by Type (2011-2016)
3.4 United States Huntington's Disease Therapeutics Sales Growth Rate by Type (2011-2016)

4 UNITED STATES HUNTINGTON'S DISEASE THERAPEUTICS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Huntington's Disease Therapeutics Sales and Market Share by Application (2011-2016)
4.2 United States Huntington's Disease Therapeutics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES HUNTINGTON'S DISEASE THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

5.1 Auspex Pharmaceuticals
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Alnylam Pharmaceuticals
  5.2.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Intellect Neurosciences Incorporation
  5.3.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Lundbeck A/S
  5.4.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Lundbeck A/S Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Prana Biotechnology Limited
  5.5.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Prana Biotechnology Limited Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Raptor Pharmaceuticals
  5.6.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Sangamo Biosciences
  5.7.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Sangamo Biosciences Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Teva Pharmaceutical Industries
  5.8.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Trophos SA
  5.9.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Trophos SA Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Valeant Pharmaceuticals International
  5.10.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Vertex Pharmaceuticals

6 HUNTINGTON'S DISEASE THERAPEUTICS MANUFACTURING COST ANALYSIS

6.1 Huntington's Disease Therapeutics Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Huntington's Disease Therapeutics

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Huntington's Disease Therapeutics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Huntington's Disease Therapeutics Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES HUNTINGTON'S DISEASE THERAPEUTICS MARKET FORECAST (2016-2021)

10.1 United States Huntington's Disease Therapeutics Sales, Revenue Forecast (2016-2021)
10.2 United States Huntington's Disease Therapeutics Sales Forecast by Type (2016-2021)
10.3 United States Huntington's Disease Therapeutics Sales Forecast by Application (2016-2021)
10.4 Huntington's Disease Therapeutics Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Huntington's Disease Therapeutics
Table Classification of Huntington's Disease Therapeutics
Figure United States Sales Market Share of Huntington's Disease Therapeutics by Type in 2015
Table Application of Huntington's Disease Therapeutics
Figure United States Sales Market Share of Huntington's Disease Therapeutics by Application in 2015
Figure United States Huntington's Disease Therapeutics Sales and Growth Rate (2011-2021)
Figure United States Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Table United States Huntington's Disease Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Huntington's Disease Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Huntington's Disease Therapeutics Sales Share by Manufacturers
Figure 2016 Huntington's Disease Therapeutics Sales Share by Manufacturers
Table United States Huntington's Disease Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Huntington's Disease Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Huntington's Disease Therapeutics Revenue Share by Manufacturers
Table 2016 United States Huntington's Disease Therapeutics Revenue Share by Manufacturers
Table United States Market Huntington's Disease Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Huntington's Disease Therapeutics Average Price of Key Manufacturers in 2015
Figure Huntington's Disease Therapeutics Market Share of Top 3 Manufacturers
Figure Huntington's Disease Therapeutics Market Share of Top 5 Manufacturers
Table United States Huntington's Disease Therapeutics Sales by Type (2011-2016)
Table United States Huntington's Disease Therapeutics Sales Share by Type (2011-2016)
Figure United States Huntington's Disease Therapeutics Sales Market Share by Type in 2015
Table United States Huntington's Disease Therapeutics Revenue and Market Share by Type (2011-2016)
Table United States Huntington's Disease Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Huntington's Disease Therapeutics by Type (2011-2016)
Table United States Huntington's Disease Therapeutics Price by Type (2011-2016)
Figure United States Huntington's Disease Therapeutics Sales Growth Rate by Type (2011-2016)
Table United States Huntington's Disease Therapeutics Sales by Application (2011-2016)
Table United States Huntington's Disease Therapeutics Sales Market Share by Application (2011-2016)
Figure United States Huntington's Disease Therapeutics Sales Market Share by Application in 2015
Table United States Huntington's Disease Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Huntington's Disease Therapeutics Sales Growth Rate by Application (2011-2016)
Table Auspex Pharmaceuticals Basic Information List
Table Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Intellect Neurosciences Incorporation Basic Information List
Table Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Lundbeck A/S Basic Information List
Table Lundbeck A/S Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lundbeck A/S Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Prana Biotechnology Limited Basic Information List
Table Prana Biotechnology Limited Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prana Biotechnology Limited Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Sangamo Biosciences Basic Information List
Table Sangamo Biosciences Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sangamo Biosciences Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Trophos SA Basic Information List
Table Trophos SA Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Trophos SA Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Valeant Pharmaceuticals International Basic Information List
Table Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Vertex Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vertex Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Huntington's Disease Therapeutics
Figure Manufacturing Process Analysis of Huntington's Disease Therapeutics
Figure Huntington's Disease Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Huntington's Disease Therapeutics Major Manufacturers in 2015
Table Major Buyers of Huntington's Disease Therapeutics
Table Distributors/Traders List
Figure United States Huntington's Disease Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure United States Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table United States Huntington's Disease Therapeutics Production Forecast by Type (2016-2021)
Table United States Huntington's Disease Therapeutics Consumption Forecast by Application (2016-2021)